WHO WE ARE
We are a dynamic, global speciality pharmaceutical company committed to bringing innovative medicines to patients.
We focus on oncology and rare diseases, making a meaningful difference to patients' lives.
We are constantly looking for highly talented individuals who, like us, are passionate and committed to helping patients live and embrace life.
On 16 March 2022, EUSA Pharma (UK) Ltd. was acquired by Recordati, an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release here.